Basilea News http://www.basilea.com/ Basilea News en Sun, 05 Sep 2010 23:17:30 +0200 Sun, 05 Sep 2010 23:17:30 +0200 Chameleon CMS webmaster@basila.com (Webmaster Webmaster) webmaster@basila.com (Webmaster Webmaster) <![CDATA[Basilea announces distribution agreement with Actelion for Toctino® in Canada]]> http://www.basilea.com/News-and-Media/Basilea-announces-distribution-agreement-with-Actelion-for-Toctino-in-Canada/371 Fri, 27 Aug 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-announces-distribution-agreement-with-Actelion-for-Toctino-in-Canada/371 <![CDATA[Basilea reports 2010 interim results]]> http://www.basilea.com/News-and-Media/Basilea-reports-2010-interim-results/369 Thu, 19 Aug 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-reports-2010-interim-results/369 <![CDATA[Data on Basilea's Toctino® in daily medical practice in Germany presented at dermatology congress]]> http://www.basilea.com/News-and-Media/Data-on-Basileas-Toctino-in-daily-medical-practice-in-Germany-presented-at-dermatology-congress/368 Fri, 30 Jul 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Data-on-Basileas-Toctino-in-daily-medical-practice-in-Germany-presented-at-dermatology-congress/368 <![CDATA[European CHMP concludes re-examination of ceftobiprole]]> http://www.basilea.com/News-and-Media/European-CHMP-concludes-re-examination-of-ceftobiprole/365 Fri, 25 Jun 2010 11:24:00 +0200 http://www.basilea.com/News-and-Media/European-CHMP-concludes-re-examination-of-ceftobiprole/365 <![CDATA[Basilea provides update on phase III program for the antifungal isavuconazole]]> http://www.basilea.com/News-and-Media/Basilea-provides-update-on-phase-III-program-for-the-antifungal-isavuconazole/363 Fri, 25 Jun 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-provides-update-on-phase-III-program-for-the-antifungal-isavuconazole/363 <![CDATA[Basilea announces distribution agreement with Almirall for Toctino® in selected European markets and Mexico]]> http://www.basilea.com/News-and-Media/Basilea-announces-distribution-agreement-with-Almirall-for-Toctino-in-selected-European-markets-and-Mexico/361 Tue, 15 Jun 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basilea-announces-distribution-agreement-with-Almirall-for-Toctino-in-selected-European-markets-and-Mexico/361 <![CDATA[Basilea's Toctino® included in treatment guidelines for chronic hand eczema in Italy]]> http://www.basilea.com/News-and-Media/Basileas-Toctino-included-in-treatment-guidelines-for-chronic-hand-eczema-in-Italy/359 Tue, 18 May 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basileas-Toctino-included-in-treatment-guidelines-for-chronic-hand-eczema-in-Italy/359 <![CDATA[Basilea's Toctino® receives marketing authorization in Italy]]> http://www.basilea.com/News-and-Media/Basileas-Toctino-receives-marketing-authorization-in-Italy/357 Mon, 03 May 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basileas-Toctino-receives-marketing-authorization-in-Italy/357 <![CDATA[Basilea's Toctino® included in expert consensus for management of chronic hand eczema in France]]> http://www.basilea.com/News-and-Media/Basileas-Toctino-included-in-expert-consensus-for-management-of-chronic-hand-eczema-in-France/355 Wed, 28 Apr 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/Basileas-Toctino-included-in-expert-consensus-for-management-of-chronic-hand-eczema-in-France/355 <![CDATA[New research data on Basilea's novel oncology drug candidate presented]]> http://www.basilea.com/News-and-Media/New-research-data-on-Basileas-novel-oncology-drug-candidate-presented/353 Wed, 21 Apr 2010 07:15:00 +0200 http://www.basilea.com/News-and-Media/New-research-data-on-Basileas-novel-oncology-drug-candidate-presented/353